Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Kahl, Sabine ^a   Straßburger, Klaus ^a   Nowotny, Bettina ^a   Livingstone, Roshan ^a   Klüppelholz, Birgit ^a   Keßel, Kathrin ^a   Hwang, Jong Hee ^a   Giani, Guido ^a   Hoffmann, Barbara ^b   Pacini, Giovanni ^c   Gastaldelli, Amalia ^d   Roden, Michael ^a,e  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^c CNR   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^e LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER; FATTY LIVER INDEX; FEMALE; GLUCOSE BLOOD LEVEL; HEPATIC STEATOSIS INDEX; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAFLD LIVER FAT SCORE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; CLINICAL TRIAL; COMPARATIVE STUDY; DRINKING BEHAVIOR; GLUCOSE TOLERANCE TEST; LIVER; OBESITY; PATHOLOGY;

ADIPOSITY; ALCOHOL DRINKING; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIVER; MALE; MIDDLE AGED;

EID: 84899649362     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094059     Document Type: Article

References (41)

1. Roden M (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2: 335-348. (Pubitemid 43885913)
2. Barsic N, Lerotic I, Smircic-Duvnjak L, Tomasic V, Duvnjak M (2012) Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 18: 3945-3954.
3. Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, et al. (2009) Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 192: 909-914.
4. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, et al. (2006) The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6: 33.
5. Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, et al. (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42: 503-508.
6. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, et al. (2009) Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137: 865-872.
7. Gastaldelli A, Kozakova M, Hojlund K, Flyvbjerg A, Favuzzi A, et al. (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49: 1537-1544.
8. Guiu B, Crevisy-Girod E, Binquet C, Duvillard L, Masson D, et al. (2012) Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1HMR spectroscopy. Eur Radiol 22: 855-863
9. Rehm J, Room R, Monteiro M, Gmel G, Graham K, et al. (2004) Alcohol use. In: Ezzati M, Lopez A, Rodgers A, Murray CJL, eds. Comparative Quantification of Health Risks: Global and regional burden of disease due to selected major risk factors. Geneva, World Health Organization. pp 959-1108.
10. Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, et al. (2005) The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 4: 10.
11. American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29 Suppl 1: S43-S48.
12. Krssak M, Hofer H, Wrba F, Meyerspeer M, Brehm A, et al. (2010) Noninvasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy. Eur J Radiol 74: e60-e66.
13. Hamilton G, Yokoo T, Bydder M, Cruite I, Schroeder ME, et al. (2011) In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed 24: 784-790.
14. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288: E462-E468. (Pubitemid 40110657)
15. Machann J, Thamer C, Stefan N, Schwenzer NF, Kantartzis K, et al. (2010) Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology 257: 353-363.
16. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062. (Pubitemid 41338752)
17. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410. (Pubitemid 32269192)
18. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24: 539-548. (Pubitemid 32198427)
19. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470. (Pubitemid 29418240)
20. Phillips DI, Clark PM, Hales CN, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11: 286-292. (Pubitemid 24144145)
21. Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 72: 298-301. (Pubitemid 43729143)
22. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672. (Pubitemid 23318125)
23. Szendroedi J, Frossard M, Klein N, Bieglmayer C, Wagner O, et al. (2012) Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans. Diabetes 61: 3176-3180.
24. Ahren B, Pacini G (1997) Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. Am J Physiol 273: E701-E707.
25. Anderwald C, Pfeiler G, Nowotny P, Anderwald-Stadler M, Krebs M, et al. (2008) Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. Eur J Clin Invest 38: 227-237. (Pubitemid 351389138)
26. Stadler M, Anderwald C, Karer T, Tura A, Kastenbauer T, et al. (2006) Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function? Diabetes Care 29: 1031-1038. (Pubitemid 44115240)
27. Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928-935. (Pubitemid 46294733)
28. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
29. Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binominal. Biometrika 26: 404-413.
30. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3: 32-35.
31. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, et al. (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42: 44-52. (Pubitemid 40911310)
32. Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, et al. (2005) Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41: 372-379. (Pubitemid 40165382)
33. Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, et al. (2006) The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 38: 485-489. (Pubitemid 44356237)
34. Bozkurt L, Gobl CS, Tura A, Chmelik M, Prikoszovich T, et al. (2012) Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One 7: e32710.
35. Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, et al. (2011) Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 54: 145-152.
36. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F (2010) Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 10: 56.
37. Perseghin G, Caumo A, Lattuada G, DeCobelli F, Esposito A, et al. (2007) Augmented fasting beta-cell secretion, and not only insulin resistance, is a feature of non-diabetic individuals with fatty liver. Diabetes 56, suppl.1: pA677.
38. Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, Mari A, et al. (2008) Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes. Eur J Endocrinol 159: 251-257.
39. Rijkelijkhuizen JM, Doesburg T, Girman CJ, Mari A, Rhodes T, et al. (2009) Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Metabolism 58: 196-203.
40. Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, et al. (2007) Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 102: 1912-1919. (Pubitemid 47301503)
41. Moriya A, Iwasaki Y, Ohguchi S, Kayashima E, Mitsumune T, et al. (2011) Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 33: 378-388.